IP Library › Granted Patent US 8,481,782
Granted Patent B2
US 8,481,782 · App. 13/151,465 · Granted Jul 9, 2013

Treprostinil production

Inventors: Hitesh Batra (Herndon, VA); Raju Penmasta (Ashburn, VA); Vijay Sharma (Olney, MD); Sudersan M. Tuladhar (Silver Spring, MD); David A. Walsh (Spotsylvania, VA)
Assignee: United Therapeutics Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,481,782
App. No.
13/151,465
Granted
Jul 9, 2013
Kind
B2
Abstract

The present invention is directed to a novel method for preparing a synthetic intermediate for treprostinil via a stereoselective alkyne addition reaction. Also described are methods of preparing treprostinil comprising the alkyne addition reaction described herein as well as novel intermediates useful for synthesis prostacyclin derivatives, such as treprostinil.

Claims (58)

1. A method of preparing a compound represented by the following structural formula:

or a pharmaceutically acceptable salt thereof, comprising:

reacting a compound represented by structural formula (I):

with a compound represented by structural formula (a):

to form a compound represented by structural formula (A):

wherein:

P 1 is an alcohol protecting group;

R is —(CH 2 ) m X;

X is COOR 1 ;

R 1 is an alkyl group; and

m is 1, 2 or 3, wherein the process further comprises:

(a) reacting the compound of structural formula (A) with a second alcohol protecting group to form a compound represented by structural formula (4):

and

(b) converting the compound of structural formula (4) to a tricyclic compound represented by structural formula (5):

(c) hydrogenating the tricyclic compound of structural formula (5) to form a hydrogenated tricyclic compound represented by structural formula (6):

and

(d) converting the hydrogenated tricyclic compound represented by structural formula (6) to a compound represented by structural formula (IX):

wherein said converting (d) accomplishes cleaving of the protective group P 1 and ester hydrolysis of R 1 in a single pot.

2. The method of claim 1 , wherein P2 is tert-butyldimethylsilyl (TBDMS), tertiarybutyldiphenylsilyl (TBDPS), triethylsilyl (TES) or triphenylmethyl (trityl group).

3. The method of claim 2 , wherein P2 is tert-butyldimethylsilyl (TBDMS).

4. The method of claim 1 , wherein P1 is tetrahydrofuranyl (THP), benzyl, 2,4-dinitrobenzyl, methoxymethyl (MOM), tertiarybutyldimethylsilyl (TBDMS), tertiarybutyldiphenylsilyl (TBDPS) or triethylsilyl (TES).

5. The method of claim 4 , wherein P1 is THP.

6. The method of claim 1 , wherein for the converting step (b), the compound of structural formula (4) is converted to the compound of structural formula (5) through a cobalt-mediated cyclization reaction.

7. The method of claim 6 , wherein the cobalt-mediated cyclization reaction is carried out in the presence of Co2(CO)8.

8. The method of claim 1 , wherein the hydrogenation reaction of step (c) is carried out in the presence of a base.

9. The method of claim 8 , wherein the base is K2CO3.

10. The method of claim 1 , wherein R1 is straight or branched C1-C5 alkyl.

11. The method of claim 10 , wherein R1 is methyl.

12. The method of claim 1 , further comprising

reacting the compound represented by formula (I):

to form the compound represented by the structural formula

13. The method of claim 1 , wherein m=1.

14. A method of preparing a compound represented by the following structural formula:

or a pharmaceutically acceptable salt thereof, comprising:

reacting a compound represented by structural formula (I):

with a compound represented by structural formula (a):

to form a compound represented by structural formula (A):

wherein:

P 1 is an alcohol protecting group;

R is —(CH 2 ) m X;

X is COOR 1 ;

R 1 is a substituted or unsubstituted benzyl group; and

m is 1, 2 or 3, wherein the process further comprises:

(a) reacting the compound of structural formula (A) with a second alcohol protecting group to form a compound represented by structural formula (4):

and

(b) converting the compound of structural formula (4) to a tricyclic compound represented by structural formula (5):

(c) hydrogenating the tricyclic compound of structural formula (5) to form a hydrogenated tricyclic compound represented by structural formula (6′):

and

(d) converting the hydrogenated tricyclic compound represented by structural formula (6′) to a compound represented by structural formula (IX):

15. The method of claim 14 , wherein the hydrogenation reaction of step (c) is carried out in the presence of a base.

16. The method of claim 15 , wherein the base is K2CO3.

17. The method of claim 14 , wherein R1 is an unsubstituted benzyl group.

18. The method of claim 14 , wherein P2 is tert-butyldimethylsilyl (TBDMS), tertiarybutyldiphenylsilyl (TBDPS), triethylsilyl (TES) or triphenylmethyl (trityl group).

19. The method of claim 18 , wherein P2 is tert-butyldimethylsilyl (TBDMS).

20. The method of claim 14 , wherein P1 is tetrahydrofuranyl (THP), benzyl, 2,4-dinitrobenzyl, methoxymethyl (MOM), tertiarybutyldimethylsilyl (TBDMS), tertiarybutyldiphenylsilyl (TBDPS) or triethylsilyl (TES).

21. The method of claim 20 , wherein P1 is THP.

22. The method of claim 14 , wherein for the converting step (b), the compound of structural formula (4) is converted to the compound of structural formula (5) through a cobalt-mediated cyclization reaction.

23. The method of claim 22 , wherein the cobalt-mediated cyclization reaction is carried out in the presence of Co2(CO)8.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2011
From: BATRA, HITESH; PENMASTA, RAJU; SHARMA, VIJAY; TULADHAR, SUDERSAN M.; WALSH, DAVID
To: UNITED THERAPEUTICS CORPORATION
Reel/Frame 026849/0489 →
Continuity (2)
Provisional Application 61351115 · Jun 3, 2010
Related Publication 20110319641A1 · Dec 29, 2011